Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Observational Study
. 2022 Jul;29(5):347-353.
doi: 10.1016/j.arcped.2022.03.004. Epub 2022 Apr 20.

Impact of COVID-19 disease on clinical research in pediatric and congenital cardiology

V Pommier  1 , H Abassi  2 , K Lavastre  1 , J Calderon  3 , S Guillaumont  4 , Y Dulac  5 , F Auriol  5 , C Ovaert  6 , A Blondelon  6 , S Hascoet  7 , F Lecerf  7 , C Jore  8 , M Avesani  8 , J-B Thambo  9 , P Amedro  10
Affiliations
Observational Study

Impact of COVID-19 disease on clinical research in pediatric and congenital cardiology

V Pommier et al. Arch Pediatr. 2022 Jul.

Abstract

Background: COVID-19 triggered an unprecedented crisis affecting society at every level. Research in pediatric and congenital cardiology is currently in full development and may have been disrupted. The aim of the study was to determine the impact of COVID-19 on pediatric and congenital cardiology clinical research and to analyze decision-making and adaptation processes, from a panel of ongoing academic and industry-sponsored research at the time of the pandemic.

Methods: This observational study was carried out in April 2020, from a CHD clinical research network involving five tertiary care pediatric and congenital cardiology centers. Investigators and clinical research assistants from each participating research center completed an online survey questionnaire, and each principal investigator underwent a 1-h web-based videoconference interview.

Results: A total of 34 study questionnaires were collected, reporting that 18 studies were totally suspended. Upon the investigator's decision, after discussion on ethical issues and with facilitating support from health authorities, 16 studies were resumed. The rate of study suspension in interventional research (53%) was similar to that in non-interventional research (56%). Logistical problems were predominantly reported in both continued and suspended trials. Research protocols were adapted, largely thanks to telemedicine, which in some cases even improved the course of the study.

Conclusion: The impact of the COVID-19 pandemic on clinical research in pediatric and congenital cardiology has been limited by a rapid adaptation of all research structures and an extensive use of telemedicine at all stages of the studies.

Keywords: Congenital heart disease; Drug trials; Pandemic; Randomized controlled trial; SARS-CoV-2.

PubMed Disclaimer

Conflict of interest statement

Declaration of competing interest None

References

    1. Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395:497–506. - PMC - PubMed
    1. Holmes EA, O'Connor RC, Perry VH, et al. Multidisciplinary research priorities for the COVID-19 pandemic: a call for action for mental health science. Lancet Psychiatry. 2020;7:547–560. - PMC - PubMed
    1. Dyck JRB. The impact of COVID-19 on diabetes research in Canada. Can J Diabetes. 2020;44:369. - PMC - PubMed
    1. Hill KD, Henderson HT, Hornik CP, et al. Paediatric cardiovascular clinical trials: an analysis of ClinicalTrials.gov and the food and drug administration pediatric drug labeling database. Cardiol Young. 2015;25(2):172–180. Suppl. - PMC - PubMed
    1. Monagle P, Lensing AWA, Thelen K, et al. Bodyweight-adjusted rivaroxaban for children with venous thromboembolism (EINSTEIN-Jr): results from three multicentre, single-arm, phase 2 studies. Lancet Haematol. 2019;6:e500–e509. - PubMed

Publication types